Webinar
Webinar
Webinar

Directions in the Treatment of Marginal Zone Lymphoma

Not a member of My prIME? Join now for instant access.

Meeting Overview

Hone your knowledge of marginal zone lymphoma (MZL) during this one hour live online webinar! Christopher Flowers, MD, from Emory Winship Cancer Institute in Atlanta, Georgia, will host an interactive discussion on MZL tumor biology and new treatments for the disease, with a focus on the application of clinical information to your practice.

You can access this webinar through your desktop computer and mobile devices.

Directions in the Treatment of Marginal Zone Lymphoma

Tuesday, December 19, 2017
3.30 PM Eastern Standard Time

Date/Time

Date/Time

Location

Location

CME

CME

5 min                    Hematology Guru: How well do you know marginal zone lymphoma?

15 min                  Marginal zone lymphoma 101: Diagnosis and tumor biology

5 min                    Questions from the audience

20 min                  2017 and beyond: What does the future hold for marginal zone lymphoma?

5 min                    Questions from the audience

5 min                    Hematology Guru: How well do you know marginal zone lymphoma?

5 min                    Conclusions and prIME Points™

Faculty

    Faculty

  • Christopher Flowers, MDEmory Winship Cancer Institute
    Atlanta, Georgia, United States

This educational activity is specifically designed to meet the needs of hematologists, oncologists, pathologists, registered nurses, and other healthcare professionals involved in the treatment of patients with marginal zone lymphoma (MZL).

After successful completion of this educational activity, participants should be able to:

  • Describe the unique biology and etiology of marginal zone lymphoma subtypes and how this influences diagnosis, prognosis, and therapeutic targeting
  • Employ appropriate treatment approaches for patients with marginal zone lymphoma based on current treatment guidelines and emerging clinical trial data
  • Evaluate recent clinical data investigating the efficacy and safety of novel treatment approaches for marginal zone lymphoma and the potential future role for these strategies in patient care

This activity is supported by educational grants from Celgene; Pharmacyclics LLC, an AbbVie Company; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Continuing Education

Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

ACCME-commendation-full-color

Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 1 contact hours may be earned for successful completion of this activity.

Provider

This activity is provided by Annenberg Center for Health Sciences at Eisenhower.